Drug Safety Communication – US FDA requests withdrawal of weight-loss drug lorcaserin

The FDA has requested that the manufacturer of lorcaserin voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. The drug is currently not available in the UK market.


US Food and Drug Administration